Almirall SA (ALM.MC) Key Developments | Reuters.com
Edition:
United States

Almirall SA (ALM.MC)

ALM.MC on Madrid SE C.A.T.S.

13.43EUR
29 Jun 2016
Change (% chg)

€0.63 (+4.92%)
Prev Close
€12.80
Open
€12.90
Day's High
€13.55
Day's Low
€12.90
Volume
326,275
Avg. Vol
243,048
52-wk High
€19.36
52-wk Low
€12.13

Latest Key Developments (Source: Significant Developments)

Almirall's CFO, Daniel Martinez, steps down
Friday, 17 Jun 2016 04:08am EDT 

Almirall SA : Says executive vice-president of finance (CFO), Daniel Martinez, steps down .Says Martinez to leave the post at end-July.  Full Article

Almirall signs US distribution deal with Sinclair Pharma
Monday, 23 May 2016 11:34am EDT 

Almirall SA : Signs through its Dallas based company Thermigen, an exclusive US strategic marketing collaboration agreement for Silhouette Instalift (TM) with Sinclair Pharma Plc .Thermigen has been initially granted with exclusive four-year distribution rights for US market until mid-2020.  Full Article

Almirall and Bicosome to jointly develop topical drug delivery formulations
Friday, 20 May 2016 03:26am EDT 

Almirall SA :Says enters into a collaboration and sublicense agreement with Bicosome to jointly develop topical drug delivery formulations.  Full Article

Almirall Q1 net profit down at 21.7 mln euros
Monday, 9 May 2016 01:59am EDT 

Almirall SA : Q1 EBITDA 54.8 million euros ($62.5 million) versus 73.1 million euros year ago . Q1 net profit 21.7 million euros versus 42.9 million euros year ago . Q1 revenue down 7.5 percent at 201.0 million euros versus year ago . Q1 research and development expenses 19.2 million euros versus 17.5 million euros year ago .Confirms FY 2016 EBITDA, sales, profit growth outlook at constant currency.  Full Article

Almirall SA sells unit and product license in Mexico for 50 mln euros
Tuesday, 15 Mar 2016 11:28am EDT 

Almirall SA:To transfer 100 percent of its Mexico's unit to Grupo Grunenthal for 30 million euros.Reaches perpetual license deal for its products in Mexico for 20 million euros.  Full Article

Almirall SA to propose FY 2015 dividend
Monday, 22 Feb 2016 02:03am EST 

Almirall SA:To propose FY 2015 dividend of 33 million euros, that is 0.19 euro per share.  Full Article

Almirall SA to execute call option for 100 pct of Thermigen‍​
Monday, 4 Jan 2016 02:04am EST 

Almirall SA:To buy 100 percent of Thermigen LLC, a company engaged in aesthetic medicine business.To execute option to buy full stake in Thermigen LLC in Jan. 2016.In Sept. Almirall acquired 7.7 pct stake in Thermigen LLC for $5 million and paid $2.5 million for a call option for up to 100 pct.  Full Article

Almirall SA to buy Poli Group Holding for 365 million euros
Monday, 30 Nov 2015 02:03am EST 

Almirall SA:Reaches deal to acquire 100 percent in Poli Group Holding for 365 million euros enterprise value.May pay additional 35 million euros in earn-outs once certain development milestones in Poli Group are met.With this acquisition Almirall will obtain a dermatology focused R&D structure.  Full Article

Almirall SA increases revenue, EBIT 2015 guidance
Tuesday, 27 Oct 2015 03:38am EDT 

Almirall SA:Says increases EBIT 2015 guidance to 130 million euros from 100 million euros.Sees 2015 revenue at between 740 million - 770 million euros, up from 720 million - 750 million euros.Says EBIT influenced by strong operational performance, boosted by receipt of $20 million from Astrazeneca for launch of Duaklir product in South Korea.FY 2015 revenue 704 million euros, EBIT 126 million euros - Thomson Reuters I/B/E/S.  Full Article

Almirall SA sells Constella/Linzess product rights to Allergan
Tuesday, 27 Oct 2015 03:27am EDT 

Almirall SA:Says sells Constella/Linzess product rights for 64 million euros ($70.8 million) to Allergan.Says divestment does not influence 2015 EBIT guidance.Says to assign extraordinary income of 35 million euros to FY 2015 net result.  Full Article

BRIEF-Almirall's CFO, Daniel Martinez, steps down

* Says executive vice-president of finance (CFO), Daniel Martinez, steps down